BCR and COVID-19: In a longitudinal multiomics COVID-19 study, the authors employed parallel scRNA-seq, single-cell BCR profiling, bulk mRNA sequencing (RNA-seq), BCR amplicon sequencing and multicolour flow cytometry from baseline to follow-up [49].